Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more tricks up its sleeve. Research out this week shows that it can do wonders for the heart. A pair of studies examined the outcomes of people at high risk of cardiovascular disease who underwent heart-related procedures. People taking tirzepatide were less likely to experience heart attacks and similar problems compared to others, including people on older GLP-1s, the studies found. These findings appear to confirm the heart-healthy benefits of tirzepatide, which is already the most effective obesity drug of its kind on the market. More than just obesity treatment Tirzepatide mimics two hormones that help regulate hunger, blood sugar, and metabolism: GLP-1 and GIP. Studies have consistently shown that tirzepatide can provide more weight loss than single-agonist GLP-1 drugs like semaglutide (Ozempic and Wegovy), ranging around 20% lost weight over a year’s time on average.…